This document summarizes clinical studies that show the superiority of suprapubic catheterization compared to transurethral catheterization. It reports that suprapubic catheterization has significantly lower infection rates, up to 87% reduction in catheter-associated urinary tract infections (CAUTIs), fewer complications, higher patient preference of 89%, and lower treatment costs. It also notes that multiple clinical studies found reductions in CAUTIs ranging from 43.3% to 86.6% with suprapubic catheterization.